The role of recombinant factor VIIa in liver transplantation

Liver Transplantation

Volumn 11, Issue 8, 2005, Pages 872-874

  Porte, Robert J ^a   Caldwell, Stephen H ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; PLACEBO; PROCOAGULANT; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING; BLOOD CLOTTING; CLINICAL TRIAL; DRUG COST; DRUG DOSE REGIMEN; DRUG MECHANISM; EDITORIAL; ERYTHROCYTE TRANSFUSION; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT INDICATION;

FACTOR VII; HUMANS; LIVER TRANSPLANTATION; RECOMBINANT PROTEINS;

EID: 23744492056     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20447     Document Type: Editorial

References (17)

1. Roberts HR, Monroe DM, Escobar MA. Current concepts of hemostasis: implications for therapy. Anesthesiology 2004;100: 727-730.
2. Porte RJ, Leebeek FW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 2002;62:2193-2211.
3. Jeffers L, Chalasani N, Balart L, Pyrsopouolos N, Erhardtsen E. Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology 2002;123:118-126.
4. Caldwell SH, Chang C, Macik BG. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials. Hepatology 2004; 39:592-598.
5. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial. Lancet 2003;361:201-205.
6. Shami V, Caldwell S, Hespenheide E, Arsenau K, Bickston S, Macik G. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003;9:138-143.
7. Bernstein DE, Jeffers L, Erhardtsen E, Reddy KR, Glazer S, Squiban P, et al. Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: a preliminary study. Gastroenterology 1997;113:1930-1937.
8. Hendriks HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation. Transplantation 2001;71:402-405.
9. Planinsic RM, van der Meer J, Testa G, et al. Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation. Liver Transpl 2005;11:895-900.
10. Lodge JP, Jonas S, Jones RM, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl 2005;11:973-979.
11. Ramos E, Dalmau A, Sabate A, Lama C, Llado L, Figueras J, Jaurrieta E. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl 2003; 9:1320-1327.
12. Porte RJ, Hendriks HG, Slooff MJ. Blood conservation in liver transplantation: the role of aprotinin. J Cardiothorac Vasc Anesth 2004;18(4suppl):31S-37S.
13. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 2003;37:233-243.
14. Boffard KD, Warren B, Law P. Decreased transfusion utilization and improved outcome associated with the use of recombinant factor VIIa as an adjunct in trauma. J Trauma 2004;57:451 (abstract).
15. Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. Lancet 2000;355:1303-1309.
16. Clavien PA. Sinusoidal endothelial cell injury during hepatic preservation and reperfusion. Hepatology 1998;28:281-285.
17. Tripodi A, Salerno F, Chantarangkul V, Clerici M, Cazzaniga M, Primignani M, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005;41:553-558.